In the last trading session, 3.48 million shares of the Royalty Pharma plc (NASDAQ:RPRX) were traded, and its beta was 0.47. Most recently the company’s share price was $27.82, and it changed around $0.0 or 0.00% from the last close, which brings the market valuation of the company to $12.43B. RPRX currently trades at a discount to its 52-week high of $36.19, offering almost -30.09% off that amount. The share price’s 52-week low was $25.92, which indicates that the current value has risen by an impressive 6.83% since then. We note from Royalty Pharma plc’s average daily trading volume that its 3-month average coming to 2.72 million.
Royalty Pharma plc (NASDAQ:RPRX) trade information
The performance over the last five days has remained in the green territory. The company’s shares are currently down -0.96% year-to-date, but still up 1.31% over the last five days. On the other hand, Royalty Pharma plc (NASDAQ:RPRX) is -8.09% down in the 30-day period.
The consensus price target as assigned by Wall Street analysts is $49, which translates to bulls needing to increase their stock price by 43.22% from its current value. Analyst projections state that RPRX is forecast to be at a low of $47 and a high of $51.
Royalty Pharma plc (RPRX) estimates and forecasts
Royalty Pharma plc share prices are performing particularly well not compared to other companies within the same industry. As is evident from the statistics, the company’s shares have risen 0.65 percent over the past six months and at a -12.03% annual growth rate that is well below the industry average of 10.30%.
Looking at the company’s year-over-year earnings, the past five years showed a positive earnings growth rate of 2.23%. Royalty Pharma plc earnings are expected to increase by -12.01% in 2024, but the outlook is positive 3.20% per year for the next five years.
RPRX Dividends
Royalty Pharma plc’s next quarterly earnings report is expected to be released in May. The annual dividend yield of the stock is 2.91 percent and its annual dividend per share was 0.81. It is important to note, however, that the 2.91% dividend yield ratio should be regarded as a guide only, as many other factors should be taken into consideration before making any investment decision.
